Crossmark

A highly specific SpCas9 variant is identified by in vivo screening in yeast

Crossref DOI link: https://doi.org/10.1038/nbt.4066

Published Online: 2018-01-29

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Casini, Antonio http://orcid.org/0000-0001-7709-4955
Olivieri, Michele http://orcid.org/0000-0002-0257-998X
Petris, Gianluca http://orcid.org/0000-0002-2420-6359
Montagna, Claudia

Reginato, Giordano

Maule, Giulia

Lorenzin, Francesca

Prandi, Davide

Romanel, Alessandro http://orcid.org/0000-0003-4855-8620
Demichelis, Francesca

Inga, Alberto

Cereseto, Anna
License Information

Text and Data Mining valid from 2018-01-29
More Information

Article History

Received: 14 March 2017

Accepted: 22 December 2017

First Online: 29 January 2018

Competing interests

: A.C., A.Ca., G.P., A.I., and M.O. are the inventors of the filed patent on the high-fidelity SpCas9 variants.